Screener
D&A at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Nutex Health Inc. in its filing.
Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.
The source filing: Nutex Health Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:03 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054268
| (In thousands, except per share amounts) | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Payroll | 42,751 | 36,284 | 84,190 | 71,144 |
| Contract services | 1,082 | 61,109 | 61,614 | 99,764 |
| Medical supplies | 5,342 | 4,812 | 9,351 | 8,613 |
| Depreciation and amortization | 5,317 | 5,248 | 10,809 | 10,340 |
| Other | 14,981 | 11,608 | 28,264 | 22,651 |
| Total operating costs and expenses | 69,473 | 119,061 | 194,228 | 212,512 |
| Gross profit | 141,279 | 124,924 | 233,009 | 243,262 |
| Corporate and other costs: |
Item 1. Financial Statements
FAQ
- What is Nutex Health Inc.'s D&A?
- Nutex Health Inc. (NUTX) reported D&A of $5.32M in Q2 2026.
- How has Nutex Health Inc.'s D&A changed year-over-year?
- Nutex Health Inc.'s D&A increased by 1.3% year-over-year, from $5.25M to $5.32M.
- What is the long-term trend for Nutex Health Inc.'s D&A?
- Over 4 years (2021 to 2025), Nutex Health Inc.'s D&A has grown at a 27.9% compound annual growth rate (CAGR), from $7.66M to $20.53M.
- What does D&A mean?
- Non-cash expense representing the systematic allocation of tangible asset costs (depreciation) and intangible asset costs (amortization) over their useful lives.
Ask your AI about Nutex Health Inc.'s d&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude